Biotechnology Fund Valuation
| RYBOX Fund | USD 65.14 0.08 0.12% |
At this time, the entity appears to be fairly valued. Biotechnology Fund Class shows a prevailing Real Value of $64.47 per share. The current price of the fund is $65.14. We determine the value of Biotechnology Fund Class from analyzing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we favor acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will blend.
Fairly Valued
Today
Please note that Biotechnology Fund's price fluctuation is very steady at this time. At this time, the entity appears to be fairly valued. Biotechnology Fund Class shows a prevailing Real Value of $64.47 per share. The current price of the fund is $65.14. We determine the value of Biotechnology Fund Class from analyzing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we favor acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will blend.
Since Biotechnology Fund is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Biotechnology Mutual Fund. However, Biotechnology Fund's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 65.14 | Real 64.47 | Hype 65.22 | Naive 64.33 |
The intrinsic value of Biotechnology Fund's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Biotechnology Fund's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Biotechnology Fund Class helps investors to forecast how Biotechnology mutual fund's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Biotechnology Fund more accurately as focusing exclusively on Biotechnology Fund's fundamentals will not take into account other important factors: Biotechnology Fund Total Value Analysis
Biotechnology Fund Class is at this time estimated to have takeover price of 0 with market capitalization of 0, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Biotechnology Fund fundamentals before making investing decisions based on enterprise value of the companyBiotechnology Fund Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Biotechnology suggests not a very effective usage of assets in June.About Biotechnology Fund Valuation
The fund valuation mechanism determines the current worth of Biotechnology Fund Class on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Biotechnology Fund Class. In general, an absolute valuation paradigm, as applied to this mutual fund, attempts to find the value of Biotechnology Fund Class based exclusively on its fundamental and basic technical indicators. By analyzing Biotechnology Fund's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Biotechnology Fund's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Biotechnology Fund. We calculate exposure to Biotechnology Fund's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Biotechnology Fund's related companies.Under normal circumstances, the fund invests substantially all of its net assets in equity securities of Biotechnology Companies that are traded in the United States and in derivatives, which primarily consist of futures contracts and options on securities, futures contracts, and stock indices. It may invest to a significant extent in the securities of Biotechnology Companies that have small to mid-sized capitalizations. The fund is non-diversified.
8 Steps to conduct Biotechnology Fund's Valuation Analysis
Mutual Fund's valuation is the process of determining the worth of any mutual fund in monetary terms. It estimates Biotechnology Fund's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of mutual fund valuation is a single number representing a Mutual Fund's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Biotechnology Fund's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Biotechnology Fund's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Biotechnology Fund's revenue streams: Identify Biotechnology Fund's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Biotechnology Fund's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Biotechnology Fund's growth potential: Evaluate Biotechnology Fund's management, business model, and growth potential.
- Determine Biotechnology Fund's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Mutual Fund's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Biotechnology Fund's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Other Information on Investing in Biotechnology Mutual Fund
Biotechnology Fund financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Fund security.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |